Physician

Adupa Rao, M.D.

According to 2025 Medicare claims, Adupa Rao, M.D. (NPI: 1558390880) practices critical care (intensivists) in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is USC CARE MEDICAL GROUP, INC (NPI: 1902846306; TIN: 954540991) and primary practice location at 90033-5313. Rao is affiliated with the Lore Health ACO (ACO ID: A5192), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 218 traditional Medicare patients, billed 517 HCPCS/CPT codes, and received $54,718 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 326 prescription claims across 42 beneficiaries totaling $1,294,557 in drug costs, led by Trikafta (Elexacaftor/Tezacaftor/Ivacaft). DME data shows 316 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $76,716 to $54,718. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $12,515 and ending at $13,157.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	155	550	$76,716
2016	154	558	$78,645
2017	144	477	$62,462
2018	166	526	$71,434
2019	230	526	$59,317
2020	175	363	$50,357
2021	162	360	$42,041
2022	227	635	$58,758
2023	218	472	$44,854
2024	218	517	$54,718

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	1,092	$1,643,937
2016	41	1,093	$2,425,660
2017	38	913	$2,043,849
2018	37	1,104	$2,571,318
2019	51	1,262	$3,518,683
2020	47	1,163	$4,794,602
2021	35	925	$4,825,865
2022	48	606	$3,801,417
2023	61	508	$2,492,929
2024	42	326	$1,294,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	78	567	$349,753
2016	107	720	$461,261
2017	53	538	$506,496
2018	41	569	$594,472
2019	37	538	$571,043
2020	33	440	$502,534
2021	35	389	$458,822
2022	35	333	$341,597
2023	43	323	$267,741
2024	13	316	$129,970

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	77	190	$173
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	31	47	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	26	39	$73
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	25	38	$61
94060	Test to measure expiratory airflow and volume changes before and after medication administration	20	20	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trikafta	Elexacaftor/Tezacaftor/Ivacaft	39	1,092	$1,010,113
Creon	Lipase/Protease/Amylase	20	642	$90,981
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	810	$16,148
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	17	507	$1,381
Albuterol Sulfate Hfa	Albuterol Sulfate	21	612	$576

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7639	Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	N	N/R	41	$121,336
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	41	$2,737
A7526	Tracheostomy tube collar/holder, each	N	N/R	21	$2,069
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	13	59	$1,397
E1392	Portable oxygen concentrator, rental	Y	N/R	36	$1,187

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Adupa Rao, M.D.?

Tedicare shows public-source Medicare data for Adupa Rao, M.D. (NPI 1558390880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adupa Rao, M.D. have ACO affiliation data?

Adupa Rao, M.D. is shown with ACO affiliation data for Lore Health ACO (MSSP, ACO ID A5192).

What billing organization is linked to Adupa Rao, M.D.?

Adupa Rao, M.D. is linked to USC CARE MEDICAL GROUP, INC (billing NPI 1902846306) in the available physician profile data.

Does Adupa Rao, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.